Advanced Lung Cancer Clinical Trials

58 clinical trials for Advanced Lung Cancer across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer — RECRUITING · PHASE1
• Nurse-Led Caregiver Support for Older Adults With Advanced Lung Cancer — RECRUITING · NA
• Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer — RECRUITING · NA
• A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection — RECRUITING · PHASE1
• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer — RECRUITING · PHASE2
• A Digital Health Intervention to Improve Physical Function and Wellness of Lung Cancer Survivors — RECRUITING · NA
• Engage Psychosocial Intervention for Cancer Symptoms — RECRUITING · NA
• Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients — RECRUITING · NA
• Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors. — RECRUITING · PHASE1
• A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer — RECRUITING · PHASE1
• Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer — RECRUITING · PHASE1
• Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer — RECRUITING · PHASE1
• Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma — RECRUITING · PHASE1
• A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer — RECRUITING · PHASE1
• A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer — RECRUITING
• A RANDOMIZED PHASE 3 STUDY OF DATOPOTAMAB DERUXTECAN (DATO-DXD) AND PEMBROLIZUMAB, WITH OR WITHOUT PLATINUM CHEMOTHERAPY, IN SUBJECTS WITH NO PRIOR THERAPY FOR ADVANCED OR METASTATIC PD-L1 TPS <50% NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WITHOUT ACTIONABLE GENOMIC ALTERATIONS (TROPION-LUNG07) — RECRUITING · PHASE3
• A PHASE 1/2 OPEN-LABEL PLATFORM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MULTIPLE AMIVANTAMAB-BASED THERAPEUTIC COMBINATIONS IN PARTICIPANTS WITH ADVANCED, UNRESECTABLE LUNG CANCER (LC) — RECRUITING · PHASE1
• PREVALENCE AND CLINICAL RELEVANCE OF VENTILATION HETEROGENEITY AND LUMINAL CELLULAR INFLAMMATION IN LUNG CANCER PATIENTS PRIOR TO LUNG RESECTION — RECRUITING
• A Phase Ib/II, multi-site, open-label, two-part trial to evaluate the efficacy, safety, pharmacokinetics, and recommended combination dose of BNT324 with BNT327 in participants with advanced lung cancer — TERMINATED · PHASE2
• A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002 — NOT_YET_RECRUITING · PHASE1
• A Pilot Study of the VosCryoTM Breathalyser in Lung Cancer — NOT_YET_RECRUITING
• Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer — NOT_YET_RECRUITING · NA
• A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer — NOT_YET_RECRUITING · PHASE1
• Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer — COMPLETED · NA
• Family-Supported Palliative Care in Advanced Lung Cancer — COMPLETED · NA
• Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures — WITHDRAWN · PHASE2
• Tier Palliative Care For Patients With Advanced Heart Failure or Cancer — NOT_YET_RECRUITING · NA
• The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension — NOT_YET_RECRUITING · PHASE2
• JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer — COMPLETED · PHASE1
• Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer — COMPLETED · PHASE2
• A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer — NOT_YET_RECRUITING · PHASE1
• Study of JS004 Combined With Toripalimab for Advanced Lung Cancer — COMPLETED · PHASE1
• Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC — NOT_YET_RECRUITING · PHASE1
• WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody — OTHER · PHASE1
• Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment. — OTHER
• Cambridge Brain Mets Trial 1 — TERMINATED · PHASE1
• A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer — COMPLETED · NA
• TIL Therapy for Patients With Advanced Solid Tumors — OTHER · PHASE1
• Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer — OTHER · NA
• A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer — COMPLETED · PHASE1
• A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC — COMPLETED · PHASE1
• IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 — OTHER · PHASE1
• A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer — OTHER · PHASE2
• The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer. — OTHER · NA
• Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers — COMPLETED · PHASE1
• Exercise, Nutrition, and Palliative Care in Advanced Lung Cancer (ENPAL) — COMPLETED · NA
• Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer — WITHDRAWN · PHASE2
• Descriptors and Predictors of Burden and Information Needs — COMPLETED
• CAR-T Cell Immunotherapy for Advanced Lung Cancer — TERMINATED · PHASE1

Refine this search